S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
OTCMKTS:EXDI

Exactus Stock Forecast, Price & News

$1.00
0.00 (0.00%)
(As of 11/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.00
$1.12
50-Day Range
$1.00
$2.77
52-Week Range
$0.04
$0.27
Volume
4,853 shs
Average Volume
83,144 shs
Market Capitalization
$599.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
4.21
30 days | 90 days | 365 days | Advanced Chart
Receive EXDI News and Ratings via Email

Sign-up to receive the latest news and ratings for Exactus and its competitors with MarketBeat's FREE daily newsletter.


About Exactus

Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:EXDI
Fax
N/A
Employees
4
Year Founded
N/A

Sales & Book Value

Annual Sales
$2.07 million
Book Value
($0.09) per share

Profitability

Net Income
$-9.46 million
Pretax Margin
-15,131.74%

Debt

Price-To-Earnings

Miscellaneous

Free Float
209,652,000
Market Cap
$599.01 million
Optionable
Not Optionable

Company Calendar

Today
11/28/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

1.27 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Exactus (OTCMKTS:EXDI) Frequently Asked Questions

How has Exactus' stock price been impacted by Coronavirus?

Exactus' stock was trading at $6.58 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EXDI stock has decreased by 84.8% and is now trading at $1.00.
View which stocks have been most impacted by COVID-19
.

When did Exactus' stock split? How did Exactus' stock split work?

Exactus shares reverse split before market open on Thursday, October 28th 2021. The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 28th 2021. An investor that had 100 shares of Exactus stock prior to the reverse split would have 4 shares after the split.

Who are Exactus' key executives?

Exactus' management team includes the following people:
  • Emiliano Aloi, President and Interim CEO
  • Kenneth E. Puzder, Chief Financial Officer and Director
  • Andrew Johnson, Chief Strategy Officer
  • Bobby Yampolsky, Interim Chairman

What other stocks do shareholders of Exactus own?

What is Exactus' stock symbol?

Exactus trades on the OTCMKTS under the ticker symbol "EXDI."

How do I buy shares of Exactus?

Shares of EXDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exactus' stock price today?

One share of EXDI stock can currently be purchased for approximately $1.00.

How much money does Exactus make?

Exactus has a market capitalization of $599.01 million and generates $2.07 million in revenue each year.

How many employees does Exactus have?

Exactus employs 4 workers across the globe.

What is Exactus' official website?

The official website for Exactus is www.exactusinc.com.

Where are Exactus' headquarters?

How can I contact Exactus?

Exactus' mailing address is 80 NE 4th Avenue Suite 28, Delray Beach FL, 33483. The company can be reached via phone at 804-205-5036.


This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.